IP Group Plc’s co-investment vehicle with major Australian superannuation fund Hostplus.

Australia’s leading independent law firm, Corrs Chambers Westgarth, has advised IP Group Plc on its first Australian institutional mandate targeting investment across life sciences and technology.

The first investment made by the IP Group Hostplus Innovation Fund is in Oxford Nanopore, the company behind the only portable, real-time DNA/RNA sequencer, MinION, whose goal is to enable the analysis of any living thing, by any person, in any environment. This low-cost DNA sequencing technology has a range of applications globally, including life-changing uses in cancer or genetic research and commercialisation in the food sector.

At the forefront of intellectual property commercialisation, UK-listed IP Group Plc partners with leading universities in the UK, US, Australia and New Zealand to build intellectual-property based businesses and provide ongoing support as ideas progress from the ‘cradle to maturity’.

IP Group recently expanded its footprint with exclusive arrangements with the ‘Group of Eight’ Australian universities and the University of Auckland, a transaction on which Corrs (led by Partner Sandy Mak) also acted for IP Group.

IP Group PLC, led by Alan John Aubrey, Gregory Simon Smith and David Baynes is based in London.

The Corrs team in IP Group’s co-investment vehicle was led by Partner Fadi Khoury (Picture).

Involved fees earner: Fadi Khoury – Corrs Chambers Westgarth;

Law Firms: Corrs Chambers Westgarth;

Clients: IP Group Plc ;


Author: Michael Patrini